Torres Xavier, Paredes-Zapata David, Revuelta Ignacio
Clinical Health Psychology Section, Psychiatry and Clinical Psychology Service, Clinic Institute of Neurosciences, Hospital Clinic, Villarroel 170, 08036, Barcelona, Spain.
Departament de Cirurgia i Especialitats Medicoquirúrgiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
J Nephrol. 2025 May;38(4):1139-1141. doi: 10.1007/s40620-025-02291-9. Epub 2025 Apr 19.
Kidney living donation remains the best treatment available for kidney failure. Most living donors report positive personal outcomes, such as enhanced life satisfaction and personal growth. However, mental health challenges have also been documented. The study by Tahir, Aftab and Nabi (J Nephrol https://doi.org/10.1007/s40620-025-02217-5 , 2025) call the attention to a small subset of living donors who may experience significant depression symptoms and occasionally suicidal ideation after donation, particularly when the recipient dies or suffers severe graft failure with a return to dialysis. As observed in the previous studies, only donors whose recipients experienced negative outcomes reported mood alterations or life dissatisfaction (Menjivar et al., Transpl Int 31(12):1332-1344, 2018). These rare post-donation risk scenarios justify a careful mental evaluation to identify psychological vulnerabilities or a history of difficulties in managing and coping with stressful situations. These adverse outcomes appear more likely in donors with pre-donation physical and/or psychological vulnerabilities, in those with a complicated surgical recovery after donation, and in cases where recipients experience poor physical or psychological outcomes. Moreover, cases of graft failure or recipient death might significantly increase donor's likelihood of depression and anxiety, Despite the generally low incidence of psychosocial problems after donation, there have been calls for a more structured and routine follow-up assessment to further mitigate risks and ensure equitable mental health safety for all kidney donors.
活体肾捐赠仍然是治疗肾衰竭的最佳可用方法。大多数活体捐赠者报告了积极的个人成果,如生活满意度提高和个人成长。然而,心理健康方面的挑战也有记录。塔希尔、阿夫塔布和纳比的研究(《肾脏病杂志》https://doi.org/10.1007/s40620-025-02217-5 ,2025年)提请注意一小部分活体捐赠者,他们在捐赠后可能会出现严重的抑郁症状,偶尔还会有自杀念头,特别是当受赠者死亡或移植器官严重衰竭并重新开始透析时。正如先前研究中所观察到的,只有受赠者出现负面结果的捐赠者才报告情绪变化或生活不满意(门吉瓦尔等人,《移植国际》31(12):1332-1344,2018年)。这些罕见的捐赠后风险情况说明需要进行仔细的心理评估,以识别心理脆弱性或在管理和应对压力情况方面有困难的历史。这些不良结果在捐赠前有身体和/或心理脆弱性的捐赠者、捐赠后手术恢复复杂的捐赠者以及受赠者身体或心理结果不佳的情况下似乎更有可能出现。此外,移植器官衰竭或受赠者死亡的情况可能会显著增加捐赠者患抑郁症和焦虑症的可能性。尽管捐赠后心理社会问题的发生率普遍较低,但仍有人呼吁进行更结构化和常规的随访评估,以进一步降低风险,并确保所有肾脏捐赠者的心理健康安全公平。